159 related articles for article (PubMed ID: 20713458)
1. Immunoassay for human serum hemojuvelin.
Brasse-Lagnel C; Poli M; Lesueur C; Grandchamp B; Lavoinne A; Beaumont C; Bekri S
Haematologica; 2010 Dec; 95(12):2031-7. PubMed ID: 20713458
[TBL] [Abstract][Full Text] [Related]
2. A novel validated enzyme-linked immunosorbent assay to quantify soluble hemojuvelin in mouse serum.
Chen W; Sun CC; Chen S; Meynard D; Babitt JL; Lin HY
Haematologica; 2013 Feb; 98(2):296-304. PubMed ID: 22875629
[TBL] [Abstract][Full Text] [Related]
3. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).
Krijt J; Fujikura Y; Ramsay AJ; Velasco G; Nečas E
Blood Cells Mol Dis; 2011 Aug; 47(2):133-7. PubMed ID: 21612955
[TBL] [Abstract][Full Text] [Related]
4. Retinal expression of the serine protease matriptase-2 (Tmprss6) and its role in retinal iron homeostasis.
Gnana-Prakasam JP; Baldowski RB; Ananth S; Martin PM; Smith SB; Ganapathy V
Mol Vis; 2014; 20():561-74. PubMed ID: 24791141
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of matriptase-2 mutations and domains: insights into the molecular basis of iron-refractory iron deficiency anemia.
McDonald CJ; Ostini L; Bennett N; Subramaniam N; Hooper J; Velasco G; Wallace DF; Subramaniam VN
Am J Physiol Cell Physiol; 2015 Apr; 308(7):C539-47. PubMed ID: 25588876
[TBL] [Abstract][Full Text] [Related]
6. Iron-refractory iron deficiency anemia.
Finberg KE
Semin Hematol; 2009 Oct; 46(4):378-86. PubMed ID: 19786206
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron-refractory iron deficiency anemia.
Choi HS; Yang HR; Song SH; Seo JY; Lee KO; Kim HJ
Pediatr Blood Cancer; 2012 Apr; 58(4):640-2. PubMed ID: 21618415
[TBL] [Abstract][Full Text] [Related]
8. Iron-refractory iron deficiency anemia (IRIDA) cases with 2 novel TMPRSS6 mutations.
Sal E; Keskin EY; Yenicesu I; Bruno M; De Falco L
Pediatr Hematol Oncol; 2016 Apr; 33(3):226-32. PubMed ID: 27120435
[TBL] [Abstract][Full Text] [Related]
9. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin.
Krijt J; Fujikura Y; Sefc L; Vokurka M; Hlobenová T; Necas E
Physiol Res; 2010; 59(1):53-59. PubMed ID: 19249912
[TBL] [Abstract][Full Text] [Related]
10. Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in
Krijt J; Frýdlová J; Gurieva I; Přikryl P; Báječný M; Steinbicker AU; Vokurka M; Truksa J
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800732
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia.
Silvestri L; Guillem F; Pagani A; Nai A; Oudin C; Silva M; Toutain F; Kannengiesser C; Beaumont C; Camaschella C; Grandchamp B
Blood; 2009 May; 113(22):5605-8. PubMed ID: 19357398
[TBL] [Abstract][Full Text] [Related]
12. Effect of Erythropoietin, Iron Deficiency and Iron Overload on Liver Matriptase-2 (TMPRSS6) Protein Content in Mice and Rats.
Frýdlová J; Přikryl P; Truksa J; Falke LL; Du X; Gurieva I; Vokurka M; Krijt J
PLoS One; 2016; 11(2):e0148540. PubMed ID: 26845567
[TBL] [Abstract][Full Text] [Related]
13. Decreased hemojuvelin protein levels in mask mice lacking matriptase-2-dependent proteolytic activity.
Frýdlová J; Fujikura Y; Vokurka M; Nečas E; Krijt J
Physiol Res; 2013; 62(4):405-11. PubMed ID: 23590607
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.
Finberg KE; Whittlesey RL; Fleming MD; Andrews NC
Blood; 2010 May; 115(18):3817-26. PubMed ID: 20200349
[TBL] [Abstract][Full Text] [Related]
15. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).
Finberg KE; Heeney MM; Campagna DR; Aydinok Y; Pearson HA; Hartman KR; Mayo MM; Samuel SM; Strouse JJ; Markianos K; Andrews NC; Fleming MD
Nat Genet; 2008 May; 40(5):569-71. PubMed ID: 18408718
[TBL] [Abstract][Full Text] [Related]
16. Iron disorders of genetic origin: a changing world.
Brissot P; Bardou-Jacquet E; Jouanolle AM; Loréal O
Trends Mol Med; 2011 Dec; 17(12):707-13. PubMed ID: 21862411
[TBL] [Abstract][Full Text] [Related]
17. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.
Ramsay AJ; Hooper JD; Folgueras AR; Velasco G; López-Otín C
Haematologica; 2009 Jun; 94(6):840-9. PubMed ID: 19377077
[TBL] [Abstract][Full Text] [Related]
18. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.
Melis MA; Cau M; Congiu R; Sole G; Barella S; Cao A; Westerman M; Cazzola M; Galanello R
Haematologica; 2008 Oct; 93(10):1473-9. PubMed ID: 18603562
[TBL] [Abstract][Full Text] [Related]
19. A novel immunological assay for hepcidin quantification in human serum.
Koliaraki V; Marinou M; Vassilakopoulos TP; Vavourakis E; Tsochatzis E; Pangalis GA; Papatheodoridis G; Stamoulakatou A; Swinkels DW; Papanikolaou G; Mamalaki A
PLoS One; 2009; 4(2):e4581. PubMed ID: 19238200
[TBL] [Abstract][Full Text] [Related]
20. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
